Therapy with tenofovir in HBV/HIV co-infected patients with resistance or partial response to lamivudine

被引：0
|
作者：
Nunez, M [1 ]
Garcia-Samantego, J [1 ]
Perez-Olmeda, M [1 ]
Romero, M [1 ]
Rios, P [1 ]
Soriano, V [1 ]
机构：
[1] Hosp Carlos Madrid, Madrid, Spain
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1892
引用
收藏
页码：636A / 636A
页数：1
相关论文
共 50 条
  • [31] Is tenofovir plus lamivudine superior to tenofovir monotherapy in patients with HBV/HIV coinfection?
    Mauss, S
    Lutz, T
    van Boemmel, F
    Berger, F
    Berg, T
    Stoehr, A
    Carlebach, A
    Schmutz, G
    JOURNAL OF HEPATOLOGY, 2005, 42 : 187 - 187
  • [32] Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?
    Mendes-Correa, Maria Cassia
    Gomes-Gouvea, Michele S.
    Alvarado-Mora, Monica V.
    Da Silva, Mariliza H.
    Lazari, Carolina
    Cavalcanti, Norma C. S.
    Alonso, Flaviane K.
    Carpinelli, Catia C.
    Uip, David E.
    Pinho, Joao R. R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (12) : E828 - E832
  • [33] Tenofovir-based combination therapy for HIV/HBV co-infection: factors associated with a partial HBV virological response in patients with undetectable HIV viraemia
    Childs, Kate
    Joshi, Deepak
    Byrne, Ruth
    Bruce, Matthew
    Carey, Ivana
    Agarwal, Kosh
    Taylor, Chris
    AIDS, 2013, 27 (09) : 1443 - 1448
  • [34] The treatment outcome of chronic HBV infection among HBV/HIV co-infected and HBV mono-infected patients
    Karic, Uros
    Milosevic, Ivana
    Pesic-Pavlovic, Ivana
    Salemovic, Dubravka
    Stojkovic, Milan
    Jevtovic, Djordje
    INTERNATIONAL JOURNAL OF STD & AIDS, 2020, 31 (01) : 38 - 45
  • [35] HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy
    Lisker-Melman, Mauricio
    Wahed, Abdus S.
    Ghany, Marc G.
    Chung, Raymond T.
    King, Wendy C.
    Kleiner, David E.
    Bhan, Atul K.
    Khalili, Mandana
    Jain, Mamta K.
    Sulkowski, Mark
    Wong, David K.
    Cloherty, Gavin
    Sterling, Richard K.
    HEPATOLOGY, 2023, 77 (02) : 594 - 605
  • [36] ENTECAVIR MONOTHERAPY SELECTS M184V MUTATION IN LAMIVUDINE-NAiVE AND LAMIVUDINE EXPERIENCED HIV-HBV CO-INFECTED PATIENTS
    Castel, Helene
    Bocket, Laurence
    Tamalet, Catherine
    Bourliere, Marc
    Yazdanpanah, Yazdan
    HEPATOLOGY, 2008, 48 (04) : 728A - 728A
  • [37] Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients
    Amponsah-Dacosta, Edina
    Selabe, Selokela G.
    Mphahlele, Maphahlaganye J.
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (02) : 291 - 303
  • [38] MDRD creatinine clearance is not altered in HIV-HBV co-infected patients with a normal renal function and treated with tenofovir (TDF)
    Lacombe, K.
    Boyd, A.
    Bonnard, P.
    Molina, J. M.
    Miailhes, P.
    Meynard, J. L.
    Taulera, L.
    Rachline, A.
    Cotte, L.
    Trylesinski, A.
    Girard, P. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S259 - S259
  • [39] Hepatitis B Virus Variants in HBV Mono-Infected Versus HBV/HIV Co-Infected Patients
    Jazayeri, Seyed Mohammad
    Alavian, Seyed Moayed
    CURRENT HIV RESEARCH, 2012, 10 (03) : 245 - 246
  • [40] Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
    Margarida Cardoso
    Joana Vasconcelos
    Teresa Baptista
    Isabel Diogo
    Fátima Gonçalves
    Kamal Mansinho
    Perpétua Gomes
    AIDS Research and Therapy, 18
12345